Rivastigmine tartrate

CAS : 129101-54-8

Ref. TM-T1628

Informations sur le produit

• Nom: Rivastigmine tartrate
• Synonymes: SDZ-ENA 713, ENA 713, 3-[(1S)-1-(dimethylamino)ethyl]phenyl ethyl(methyl)carbamate 2,3-dihydroxybutanedioate (1:1), 3-[(1S)-1-(dimethylamino)ethyl]phenyl ethyl(methyl)carbamate 2,3-dihydroxybutanedioate (salt), Carbamic acid, N-ethyl-N-methyl-, 3-[(1S)-1-(dimethylamino)ethyl]phenyl ester, (2R,3R)-2,3-dihydroxybutanedioate (1:1), Carbamic acid, ethylmethyl-, 3-((1S)-1-(dimethylamino)ethyl)phenyl ester, (2R,3R)-2,3-dihydroxybutanedioate (1:1), Carbamic acid, ethylmethyl-, 3-(1-(dimethylamino)ethyl)phenyl ester, (S)-, (R-(R*,R*))-2,3-dihydroxybutanedioate (1:1), Ena 713, Rivastigimine tartrate, Rivastigmine Bitartrate, Rivastigmine hydrogen tartrate, Rivastigmine hydrogentartrate, Sdz-Ena 713, Unii-9Iy2357Jpe
• CAS: 129101-54-8

Description

Rivastigmine tartrate (SDZ-ENA 713) is a carbamate-derived reversible CHOLINESTERASE INHIBITOR that is selective for the CENTRAL NERVOUS SYSTEM and is used for the treatment of DEMENTIA in ALZHEIMER DISEASE and PARKINSON DISEASE.

• Marque: Targetmol

Propriétés chimiques

• Masse moléculaire: 400.43
• Formule: C₁₄H₂₂N₂O₂·C₄H₆O₆
• Degré de pureté: 99.66%
• Couleur/Forme: White To Off-White Powder